GlassScriptPhysician profile
Jae Y Kim
NPI 1497287635
$1,325.38
in general payments reported to CMS, 2019-2025
17 companies · $280 in 2025
The $280 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2020: $23.38 · 2021: $64.97 · 2022: $45.76 · 2023: $262 · 2024: $510 · 2025: $280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $965 · Entertainment: $88.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $964.61 |
| Entertainment | $88.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alimera Sciences, INC. | $326.69 | 2024 | Yutiq, Iluvien |
| Alcon Vision LLC | $227.14 | 2019-2024 | Rocklatan, Lensx, Eysuvis |
| Alcon Research LLC | $158.06 | 2025 | |
| Sun Pharmaceutical Industries INC. | $98.31 | 2022-2025 | |
| Optos, INC. | $88.09 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Abbvie INC. | $80.83 | 2023-2024 | |
| Glaukos Corporation | $64.97 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $52.49 | 2022-2023 | Tecnis Simplicity |
| Tarsus Pharmaceuticals, INC. | $50.00 | 2024-2025 | Xdemvy |
| Rxsight INC | $30.73 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Light Adjustable Lens (Lal) |
| New World Medical,INC. | $29.14 | 2024 | Kahook Dual Blade, Streamline, Ahmed Glaucoma Valve |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $23.38 | 2020 | |
| Biotissue Holdings INC. | $23.29 | 2025 | |
| Bausch & Lomb Americas INC. | $21.08 | 2024 | Miebo, Xiidra |
| Dompe US, INC. | $20.21 | 2024 | Oxervate |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $16.54 | 2023 | |
| Ocular Therapeutix, INC. | $14.43 | 2023 | Dextenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jae Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.